News & EventsAsh Harris2026-05-28T21:54:40+00:00

News & Events

News

Ionetix Begins Shipping Astatine-211 to Support Preclinical and Clinical Trials
September 1, 2026
Ionetix Appoints Paul Surdez as Head of Investor Relations
August 17, 2026
Ionetix Announces Approval of Abbreviated New Drug Application for Gallium Ga-68 Gozetotide (PSMA-11)
May 26, 2026
Ionetix Completes $30 million+ Financing in a Go-Public Transaction
April 21, 2026
IONETIX Corporation and AlfaRim Medical B.V. announce a strategic partnership to fast-track commercial production of Actinium-225
June 20, 2025
IONETIX Invests $25.75M in Delta Township Facility, Creating 53 High-Tech Jobs and Advancing Lansing’s MedTech Leadership
June 6, 2025

Upcoming Events

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

News & Events

News & Events

News

Ionetix Begins Shipping Astatine-211 to Support Preclinical and Clinical Trials

September 1, 2026

Ionetix Appoints Paul Surdez as Head of Investor Relations

August 17, 2026

Ionetix Announces Approval of Abbreviated New Drug Application for Gallium Ga-68 Gozetotide (PSMA-11)

May 26, 2026

Ionetix Completes $30 million+ Financing in a Go-Public Transaction

April 21, 2026

IONETIX Corporation and AlfaRim Medical B.V. announce a strategic partnership to fast-track commercial production of Actinium-225

June 20, 2025

IONETIX Invests $25.75M in Delta Township Facility, Creating 53 High-Tech Jobs and Advancing Lansing’s MedTech Leadership

June 6, 2025

Upcoming Events

Sitemap

Get social